Triazolam and Intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Intestinal obstruction is reported as a side effect among people who take Triazolam (triazolam), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Lidocaine, and have Constipation.

The phase IV clinical study analyzes which people have Intestinal obstruction when taking Triazolam. It is created by eHealthMe based on reports of 5,701 people who have side effects when taking Triazolam from the FDA, and is updated regularly.

What is Triazolam?

Triazolam has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 5,838 Triazolam users. Check the latest studies of Triazolam.

What is Intestinal obstruction?

Intestinal obstruction is found to be associated with 1,885 drugs and 2,619 conditions by eHealthMe. Check the latest studies of Intestinal obstruction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

5,701 people reported to have side effects when taking Triazolam.
Among them, 41 people (0.72%) have Intestinal obstruction.

Could Triazolam cause Intestinal obstruction?

Among these 41 people:

How long have people been on Triazolam when they have Intestinal obstruction? *

What is the gender of people who have Intestinal obstruction when taking Triazolam? *

female: 75 %
male: 25 %

What is the age of people who have Intestinal obstruction when taking Triazolam? *

What are other drugs people take besides Triazolam? *

What are other side effects people have besides Intestinal obstruction? *

Dyspnea (difficult or laboured breathing): 9 people, 21.95%
Pneumonia: 8 people, 19.51%
Abdominal Pain Upper: 6 people, 14.63%
Abdominal Pain: 6 people, 14.63%
Abdominal Distension: 5 people, 12.20%
Headache (pain in head): 5 people, 12.20%
Pelvic Adhesions: 5 people, 12.20%
Pain: 5 people, 12.20%
Ovarian Adhesion (bands of scar-like tissue that form between ovary and nearby organ): 5 people, 12.20%
Nausea And Vomiting: 5 people, 12.20%

What are the existing conditions these people have? *

Constipation: 7 people, 17.07%
Diabetes: 5 people, 12.20%
High Blood Pressure: 5 people, 12.20%
Immunodeficiency Common Variable: 4 people, 9.76%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 7.32%
Diarrhea: 3 people, 7.32%
Breast Cancer: 3 people, 7.32%
Type 2 Diabetes: 3 people, 7.32%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 7.32%
Osteoporosis (bones weak and more likely to break): 2 people, 4.88%

* Approximation only. Some reports may have incomplete information.

Do you take Triazolam and have Intestinal obstruction?

- Check whether Intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triazolam:

Triazolam (5,838 reports)

Browse all side effects of Triazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intestinal obstruction:

Intestinal obstruction (1,885 drugs)

Browse all the conditions that are associated with Intestinal obstruction:

Intestinal obstruction (2,619 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triazolam (the active ingredients of Triazolam) and Triazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.